YWHAQ and schizophrenia: To build upon the behavioral and molecular abnormalities found in our models of 14-3-3 inhibition, our lab investigated the role of 14-3-3 proteins in neural oscillations, which are dysfunctional in schizophrenia patients (Jones et al., 2021).